Sol-Gel Technologies Ltd. Operating Expenses 2011-2026 | SLGL

Annual Operating Expenses Sol-Gel Technologies Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	48.9 M	33.6 M	31.8 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
48.9 M	31.8 M	38.1 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Coherus BioSciences CHRS	231 M	$ 1.57	-3.68 %	$ 184 M	USA
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	216 M	$ 16.87	-2.49 %	$ 789 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	158 M	$ 7.47	-4.6 %	$ 205 M	Israel
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Eton Pharmaceuticals ETON	43.6 M	$ 30.26	1.0 %	$ 814 M	USA
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Exelixis EXEL	598 M	$ 50.13	-1.9 %	$ 13.6 B	USA
Fortress Biotech FBIO	125 M	$ 2.41	4.78 %	$ 67.2 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Forte Biosciences FBRX	70.7 M	$ 23.11	-3.55 %	$ 299 M	USA
AbCellera Biologics ABCL	292 M	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	145 M	$ 1.63	2.52 %	$ 434 M	Britain
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
BioNTech SE BNTX	512 M	$ 89.55	-2.65 %	$ 21.6 B	Germany
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.17	-7.66 %	$ 139 M	USA
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
IMV IMV	35.1 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Gilead Sciences GILD	13.5 B	$ 129.58	-1.88 %	$ 161 B	USA
Advaxis ADXS	19.6 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	10.4 M	$ 3.36	-3.72 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	19.3 M	$ 0.72	-1.58 %	$ 32.9 M	Israel
Esperion Therapeutics ESPR	343 M	$ 3.12	-	$ 649 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Genmab A/S GMAB	67.9 M	$ 26.54	-1.34 %	$ 1.72 B	Danmark
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA